EcoDrugPlus

Hypocretin Receptor 2

Ensembl ID : ENSPEMG00000018057
Gene Symbol: HCRTR2
3 Cross references
201 Possible Orthologues:

Indoleamine 2,3-Dioxygenase 1

Ensembl ID : ENSPEMG00000010119
Gene Symbol: IDO1
3 Cross references
98 Possible Orthologues:

Inhibitor Of Kappab Kinase Beta

Ensembl ID : ENSPEMG00000015525
Gene Symbol: IKBKB
1 Cross references
197 Possible Orthologues:

Inosine Monophosphate Dehydrogenase 1

Ensembl ID : ENSPEMG00000014779
Gene Symbol: IMPDH1
1 Cross references
333 Possible Orthologues:

Inosine Monophosphate Dehydrogenase 2

Ensembl ID : ENSPEMG00000005350
Gene Symbol: IMPDH2
3 Cross references
200 Possible Orthologues:

Inositol Polyphosphate-5-Phosphatase D

Ensembl ID : ENSPEMG00000007040
Gene Symbol: INPP5D
3 Cross references
213 Possible Orthologues:

Insulin Receptor

Ensembl ID : ENSPEMG00000016970
Gene Symbol: INSR
1 Cross references
288 Possible Orthologues:

Insulin-Like Growth Factor I Receptor

Ensembl ID : ENSPEMG00000015935
Gene Symbol: IGF1R
1 Cross references
274 Possible Orthologues:

Integrin Alpha 2b

Ensembl ID : ENSPEMG00000000114
Gene Symbol: ITGA2B
1 Cross references
189 Possible Orthologues:

Integrin Alpha 5 (Fibronectin Receptor Alpha)

Ensembl ID : ENSPEMG00000000509
Gene Symbol: ITGA5
1 Cross references
269 Possible Orthologues:

Integrin Alpha V

Ensembl ID : ENSPEMG00000015518
Gene Symbol: ITGAV
1 Cross references
243 Possible Orthologues:

Integrin Beta 7

Ensembl ID : ENSPEMG00000016354
Gene Symbol: ITGB7
1 Cross references
160 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).